ArticleFrontiers in pharmacology2024

Case report: Sustained complete remission with all-oral MEPED therapy in a patient with Hodgkin's disease developing resistance to pembrolizumab.

K Reuthner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.